Abstract
Computational drug design based on artificial intelligence is an emerging research area. At the time of writing this paper, the world suffers from an outbreak of the coronavirus SARS-CoV-2. A promising way to stop the virus replication is via protease inhibition. We propose an evolutionary multi-objective algorithm (EMOA) to design potential protease inhibitors for SARS-CoV-2 ’s main protease. Based on the SELFIES representation the EMOA maximizes the binding of candidate ligands to the protein using the docking tool QuickVina 2, while at the same time taking into account further objectives like drug-likeness or the fulfillment of filter constraints. The experimental part analyzes the evolutionary process and discusses the inhibitor candidates.
Author supplied keywords
Cite
CITATION STYLE
Cofala, T., Elend, L., Mirbach, P., Prellberg, J., Teusch, T., & Kramer, O. (2020). Evolutionary multi-objective design of sars-cov-2 protease inhibitor candidates. In Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) (Vol. 12270 LNCS, pp. 357–371). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/978-3-030-58115-2_25
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
